Insider · CIK 0001774702
Yann Mazabraud
Files at RYTM (RHYTHM PHARMACEUTICALS, INC.). First filing Apr 10, 2025, latest May 1, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RYTM: RHYTHM PHARMACEUTICALS, INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 25Weak | RHYTHM PHARMACEUTICALS, INC. | $439k 6,745 shares | -15% | +39% from low-3% from high | |
| 38Weak | RHYTHM PHARMACEUTICALS, INC. | $1.1M 17,750 shares | -44% | +23% from low-14% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 29, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -6,745 | $65.08 | $439k | 37,655 | May 1, 2025 |
| Apr 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +10,375 | - | - | 32,995 | Apr 16, 2025 |
| Apr 15, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Common Stock | +11,405 | - | - | 44,400 | Apr 16, 2025 |
| Apr 14, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -10,375 | $0.00 | $0 | 20,750 | Apr 16, 2025 |
| Apr 15, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -8,905 | $0.00 | $0 | 0 | Apr 16, 2025 |
| Apr 15, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | MOption exercise Restricted Stock Unitsderivative | -2,500 | $0.00 | $0 | 7,500 | Apr 16, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -8,438 | $60.37 | $509k | 31,932 | Apr 10, 2025 |
| Apr 8, 2025 | RYTM RHYTHM PHARMACEUTICALS, INC. | SOpen-market sale Common Stock10b5-1 | -9,312 | $61.54 | $573k | 22,620 | Apr 10, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.